Remnant epitopes, autoimmunity and glycosylation

Area of Science:

• Immunology
• Biochemistry
• Molecular Biology

Background:

• Extracellular proteolysis, cytokines, and chemokines are key in autoimmune diseases.
• Many of these molecules are glycoproteins, with glycosylation regulating their function.
• Matrix metalloproteinase-9 (MMP-9) is a glycosylated enzyme implicated in autoimmunity.

Purpose of the Study:

• To investigate the role of glycosylated matrix metalloproteinase-9 (MMP-9) in autoimmune processes.
• To understand how MMP-9 influences immune cell recruitment and collagen degradation in rheumatoid arthritis.
• To assess the impact of MMP-9 on innate immunity effector molecules like interferon-beta.

Main Methods:

• Studied MMP-9's role in rheumatoid arthritis joint tissues.
• Analyzed chemokine-mediated neutrophil and lymphocyte recruitment.
• Investigated MMP-9's cleavage of collagen type II and subsequent peptide generation.
• Assessed MMP-9's degradation of interferon-beta and the effect of interferon-beta glycosylation.

Main Results:

• MMP-9 potentiates interleukin-8, increasing immune cell influx into joints.
• MMP-9 cleaves collagen type II into peptides, two of which are immunodominant and stimulate autoimmune T cells.
• One immunodominant collagen fragment contains a critical glycan for immunoreactivity.
• MMP-9 degrades interferon-beta, reducing innate immunity efficacy.
• Glycosylated interferon-beta shows increased resistance to MMP-9 proteolysis.

Conclusions:

• Glycosylation is mechanistically vital in autoimmune disease pathogenesis.
• Targeting glycosylated proteinases, like MMP-9, is a potential therapeutic avenue.
• Utilizing glycosylated cytokines may be critical for treating autoimmune diseases.